Arachidonylethanolamide (AEA, """"""""anandamide"""""""") is a constituent lipid in brain that activates the CB1 cannabinoid receptor. While a growing body of evidence supports the hypothesis that AEA is an agonist of the CB1 receptor in vitro,many fundamental questions regarding the role of AEA in the brain remain unanswered. The overall hypothesis of this application is that an AEA/CB 1 signaling system operates in the brain. Furthermore, we hypothesize that three proteins involved in this signaling system: phospholipase D (PLD); an AEA transport protein; and fatty acyl amide hydrolase (FAAH) are subject to regulation by signaling cascades in neurons. These experiments will begin to explore the integration of the endocannabinoids into signaling processes in the brain. The following specif aboutc aims will be used to test this hypothesis. (1.) The phospholipase D (PLD) involved in AEA synthesis will be characterized. We will design and synthesize inhibitors and test their activity and specificity. We will detennine whether the relatively well characterized isoforms of PLD (PLDI and PLD2) synthesis AE4 from N-arachidonylPE; (2.) AEA is moved across cell membranes by a protein carrier. We will determine whether the driving force for AEA accumulation by cells is sequestration of AEA by an intracellular protein or membrane lipid or catabolism of AEA intracellularly. We will optimize inhibitors of the AEA carrier. (3.) Fatty acid arnide hydrolase (FAAH) is a microsomal enzyme that hydrolyzes AEA. We will elucidate the active site of FAAH using an inhibitor that covalently bonds to active site residues. We will deterrnine whether FAAH associates with other cellular proteins via an SH3 binding domain. This project is a collaboration among scientists with expertise in lipid chemistry and biochemistry; synthetic and analytical chemistry of arachidonic acid analogs; biochemical enzymology and cannabinoid receptor pharmacology. We anticipate that successful completion of these studies will provide valuable insight into the role of the AEA/CB 1 signaling system in the brain.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009155-06
Application #
6378588
Study Section
Special Emphasis Panel (ZRG1-MDCN-5 (01))
Program Officer
Rapaka, Rao
Project Start
1996-04-01
Project End
2005-05-31
Budget Start
2001-07-01
Budget End
2002-05-31
Support Year
6
Fiscal Year
2001
Total Cost
$293,711
Indirect Cost
Name
Medical College of Wisconsin
Department
Pharmacology
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Nithipatikom, Kasem; Endsley, Michael P; Pfeiffer, Adam W et al. (2014) A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol. J Lipid Res 55:2093-102
Liedhegner, Elizabeth Sabens; Vogt, Caleb D; Sem, Daniel S et al. (2014) Sterol carrier protein-2: binding protein for endocannabinoids. Mol Neurobiol 50:149-58
Liedhegner, Elizabeth Sabens; Sasman, Amy; Hillard, Cecilia J (2014) Brain region-specific changes in N-acylethanolamine contents with time of day. J Neurochem 128:491-506
Lee, Tiffany T-Y; Hill, Matthew N; Hillard, Cecilia J et al. (2013) Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. Synapse 67:4-10
Hill, M N; Kumar, S A; Filipski, S B et al. (2013) Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry 18:1125-35
Wang, Meina; Hill, Matthew N; Zhang, Longhua et al. (2012) Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J Psychopharmacol 26:56-70
Roberts, C J; Stuhr, K L; Hillard, C J (2012) Swim stress differentially affects limbic contents of 2-arachidonoylglycerol and 2-oleoylglycerol. Neuroscience 204:74-82
Vaughn, L K; Mantsch, J R; Vranjkovic, O et al. (2012) Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. Neuroscience 204:117-24
Nithipatikom, Kasem; Gomez-Granados, Ana Doris; Tang, Alan T et al. (2012) Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells. Endocrinology 153:29-41
McLaughlin, Ryan J; Hill, Matthew N; Bambico, Francis R et al. (2012) Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. Eur Neuropsychopharmacol 22:664-71

Showing the most recent 10 out of 73 publications